Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Parkinson's Disease (PD) Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Parkinson's Disease (PD) Drugsmarket, defines the market attractiveness level of Parkinson's Disease (PD) Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Parkinson's Disease (PD) Drugs industry, describes the types of Parkinson's Disease (PD) Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Parkinson's Disease (PD) Drugs market and the development prospects and opportunities of Parkinson's Disease (PD) Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Parkinson's Disease (PD) Drugs market in Chapter 13.
By Player:
Biogen
Impax Laboratories
H Lundbeck
F Hoffmann-La Roche
Eisai
GlaxoSmithKline
Eli Lilly
Novartis
Addex Therapeutics
Teva Pharmaceutical Industries
Kyowa Hakko Kirin
Otsuka Pharmaceutical
Pfizer
Abital Pharma
Boehringer Ingelheim
AbbVie
By Type:
Dopamine Agonist
Monoamine Oxidase Inhibitors
Acetylcholinesterase Inhibitors
Glutamate Inhibitors
By End-User:
Hospital
Family
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Parkinson's Disease (PD) Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Parkinson's Disease (PD) Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Parkinson's Disease (PD) Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Parkinson's Disease (PD) Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Parkinson's Disease (PD) Drugs Market Analysis and Outlook to 2022
-
7.1 Global Parkinson's Disease (PD) Drugs Consumption (2017-2022)
-
7.2 United States Parkinson's Disease (PD) Drugs Consumption (2017-2022)
-
7.3 Europe Parkinson's Disease (PD) Drugs Consumption (2017-2022)
-
7.4 China Parkinson's Disease (PD) Drugs Consumption (2017-2022)
-
7.5 Japan Parkinson's Disease (PD) Drugs Consumption (2017-2022)
-
7.6 India Parkinson's Disease (PD) Drugs Consumption (2017-2022)
-
7.7 South Korea Parkinson's Disease (PD) Drugs Consumption (2017-2022)
8 Region and Country-wise Parkinson's Disease (PD) Drugs Market Analysis and Outlook to 2028
-
8.1 Global Parkinson's Disease (PD) Drugs Consumption Forecast (2022-2028)
-
8.2 United States Parkinson's Disease (PD) Drugs Consumption Forecast (2022-2028)
-
8.3 Europe Parkinson's Disease (PD) Drugs Consumption Forecast (2022-2028)
-
8.4 China Parkinson's Disease (PD) Drugs Consumption Forecast (2022-2028)
-
8.5 Japan Parkinson's Disease (PD) Drugs Consumption Forecast (2022-2028)
-
8.6 India Parkinson's Disease (PD) Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea Parkinson's Disease (PD) Drugs Consumption Forecast (2022-2028)
9 Global Parkinson's Disease (PD) Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Parkinson's Disease (PD) Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Dopamine Agonist Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Monoamine Oxidase Inhibitors Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Acetylcholinesterase Inhibitors Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Glutamate Inhibitors Consumption and Growth Rate (2017-2022)
-
9.2 Global Parkinson's Disease (PD) Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Family Consumption and Growth Rate (2017-2022)
10 Global Parkinson's Disease (PD) Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global Parkinson's Disease (PD) Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Dopamine Agonist Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Monoamine Oxidase Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Acetylcholinesterase Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Glutamate Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Parkinson's Disease (PD) Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Family Consumption Forecast and Growth Rate (2022-2028)
11 Global Parkinson's Disease (PD) Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Parkinson's Disease (PD) Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Parkinson's Disease (PD) Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Parkinson's Disease (PD) Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Parkinson's Disease (PD) Drugs Market Competitive Analysis
-
14.1 Biogen
-
14.1.1 Biogen Company Details
-
14.1.2 Biogen Parkinson's Disease (PD) Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Biogen Parkinson's Disease (PD) Drugs Product and Service
-
14.2 Impax Laboratories
-
14.2.1 Impax Laboratories Company Details
-
14.2.2 Impax Laboratories Parkinson's Disease (PD) Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Impax Laboratories Parkinson's Disease (PD) Drugs Product and Service
-
14.3 H Lundbeck
-
14.3.1 H Lundbeck Company Details
-
14.3.2 H Lundbeck Parkinson's Disease (PD) Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 H Lundbeck Parkinson's Disease (PD) Drugs Product and Service
-
14.4 F Hoffmann-La Roche
-
14.4.1 F Hoffmann-La Roche Company Details
-
14.4.2 F Hoffmann-La Roche Parkinson's Disease (PD) Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 F Hoffmann-La Roche Parkinson's Disease (PD) Drugs Product and Service
-
14.5 Eisai
-
14.5.1 Eisai Company Details
-
14.5.2 Eisai Parkinson's Disease (PD) Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Eisai Parkinson's Disease (PD) Drugs Product and Service
-
14.6 GlaxoSmithKline
-
14.6.1 GlaxoSmithKline Company Details
-
14.6.2 GlaxoSmithKline Parkinson's Disease (PD) Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 GlaxoSmithKline Parkinson's Disease (PD) Drugs Product and Service
-
14.7 Eli Lilly
-
14.7.1 Eli Lilly Company Details
-
14.7.2 Eli Lilly Parkinson's Disease (PD) Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Eli Lilly Parkinson's Disease (PD) Drugs Product and Service
-
14.8 Novartis
-
14.8.1 Novartis Company Details
-
14.8.2 Novartis Parkinson's Disease (PD) Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Novartis Parkinson's Disease (PD) Drugs Product and Service
-
14.9 Addex Therapeutics
-
14.9.1 Addex Therapeutics Company Details
-
14.9.2 Addex Therapeutics Parkinson's Disease (PD) Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Addex Therapeutics Parkinson's Disease (PD) Drugs Product and Service
-
14.10 Teva Pharmaceutical Industries
-
14.10.1 Teva Pharmaceutical Industries Company Details
-
14.10.2 Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Product and Service
-
14.11 Kyowa Hakko Kirin
-
14.11.1 Kyowa Hakko Kirin Company Details
-
14.11.2 Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Product and Service
-
14.12 Otsuka Pharmaceutical
-
14.12.1 Otsuka Pharmaceutical Company Details
-
14.12.2 Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Product and Service
-
14.13 Pfizer
-
14.13.1 Pfizer Company Details
-
14.13.2 Pfizer Parkinson's Disease (PD) Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 Pfizer Parkinson's Disease (PD) Drugs Product and Service
-
14.14 Abital Pharma
-
14.14.1 Abital Pharma Company Details
-
14.14.2 Abital Pharma Parkinson's Disease (PD) Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.14.3 Abital Pharma Parkinson's Disease (PD) Drugs Product and Service
-
14.15 Boehringer Ingelheim
-
14.15.1 Boehringer Ingelheim Company Details
-
14.15.2 Boehringer Ingelheim Parkinson's Disease (PD) Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.15.3 Boehringer Ingelheim Parkinson's Disease (PD) Drugs Product and Service
-
14.16 AbbVie
-
14.16.1 AbbVie Company Details
-
14.16.2 AbbVie Parkinson's Disease (PD) Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.16.3 AbbVie Parkinson's Disease (PD) Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Parkinson's Disease (PD) Drugs
-
Figure Parkinson's Disease (PD) Drugs Picture
-
Table Global Parkinson's Disease (PD) Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Parkinson's Disease (PD) Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Parkinson's Disease (PD) Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Parkinson's Disease (PD) Drugs Consumption by Country (2017-2022)
-
Figure United States Parkinson's Disease (PD) Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Parkinson's Disease (PD) Drugs Consumption and Growth Rate (2017-2022)
-
Figure China Parkinson's Disease (PD) Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Parkinson's Disease (PD) Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Parkinson's Disease (PD) Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Parkinson's Disease (PD) Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Parkinson's Disease (PD) Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Parkinson's Disease (PD) Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Parkinson's Disease (PD) Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Parkinson's Disease (PD) Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Parkinson's Disease (PD) Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Parkinson's Disease (PD) Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Parkinson's Disease (PD) Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Dopamine Agonist Consumption and Growth Rate (2017-2022)
-
Figure Global Monoamine Oxidase Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global Acetylcholinesterase Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global Glutamate Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Family Consumption and Growth Rate (2017-2022)
-
Figure Global Dopamine Agonist Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Monoamine Oxidase Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Acetylcholinesterase Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Glutamate Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Family Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Parkinson's Disease (PD) Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Parkinson's Disease (PD) Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table Biogen (Foundation Year, Company Profile and etc.)
-
Table Biogen Parkinson's Disease (PD) Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biogen Parkinson's Disease (PD) Drugs Product and Service
-
Table Impax Laboratories (Foundation Year, Company Profile and etc.)
-
Table Impax Laboratories Parkinson's Disease (PD) Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Impax Laboratories Parkinson's Disease (PD) Drugs Product and Service
-
Table H Lundbeck (Foundation Year, Company Profile and etc.)
-
Table H Lundbeck Parkinson's Disease (PD) Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table H Lundbeck Parkinson's Disease (PD) Drugs Product and Service
-
Table F Hoffmann-La Roche (Foundation Year, Company Profile and etc.)
-
Table F Hoffmann-La Roche Parkinson's Disease (PD) Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table F Hoffmann-La Roche Parkinson's Disease (PD) Drugs Product and Service
-
Table Eisai (Foundation Year, Company Profile and etc.)
-
Table Eisai Parkinson's Disease (PD) Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eisai Parkinson's Disease (PD) Drugs Product and Service
-
Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Parkinson's Disease (PD) Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Parkinson's Disease (PD) Drugs Product and Service
-
Table Eli Lilly (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly Parkinson's Disease (PD) Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly Parkinson's Disease (PD) Drugs Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Parkinson's Disease (PD) Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Parkinson's Disease (PD) Drugs Product and Service
-
Table Addex Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Addex Therapeutics Parkinson's Disease (PD) Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Addex Therapeutics Parkinson's Disease (PD) Drugs Product and Service
-
Table Teva Pharmaceutical Industries (Foundation Year, Company Profile and etc.)
-
Table Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Product and Service
-
Table Kyowa Hakko Kirin (Foundation Year, Company Profile and etc.)
-
Table Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Product and Service
-
Table Otsuka Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Parkinson's Disease (PD) Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Parkinson's Disease (PD) Drugs Product and Service
-
Table Abital Pharma (Foundation Year, Company Profile and etc.)
-
Table Abital Pharma Parkinson's Disease (PD) Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abital Pharma Parkinson's Disease (PD) Drugs Product and Service
-
Table Boehringer Ingelheim (Foundation Year, Company Profile and etc.)
-
Table Boehringer Ingelheim Parkinson's Disease (PD) Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Boehringer Ingelheim Parkinson's Disease (PD) Drugs Product and Service
-
Table AbbVie (Foundation Year, Company Profile and etc.)
-
Table AbbVie Parkinson's Disease (PD) Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table AbbVie Parkinson's Disease (PD) Drugs Product and Service
-
